Stockscreener 앱 받기
2.37
2.07%
-0.05
전일 마감가:
$2.42
열려 있는:
$2.48
하루 거래량:
24,506
Relative Volume:
0.22
시가총액:
$2.32M
수익:
$1.10M
순이익/손실:
$-11.23M
주가수익비율:
-1.1704
EPS:
-2.025
순현금흐름:
$-6.61M
1주 성능:
-17.42%
1개월 성능:
-4.30%
6개월 성능:
-69.90%
1년 성능:
-90.76%
1일 변동 폭
$2.36
$2.50
1주일 범위
$2.36
$2.85
52주 변동 폭
$2.2577
$28.35
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
명칭
Matinas Biopharma Holdings Inc
전화
908-443-1860
주소
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
2.37 | 2.32M | 1.10M | -11.23M | -6.61M | -2.025 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | 재개 | Piper Sandler | Overweight |
| 2020-01-27 | 개시 | Piper Sandler | Overweight |
| 2020-01-24 | 개시 | SunTrust | Buy |
| 2020-01-23 | 개시 | SunTrust | Buy |
| 2020-01-09 | 개시 | Aegis Capital | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
모두보기
Matinas Biopharma Holdings Inc 주식(MTNB)의 최신 뉴스
Stock splits calendar for: - Yahoo Finance Australia
Matinas BioPharma Holdings, Inc.: Dividend historical data and projections - marketscreener.com
MTNB Q4 2024 Earnings: Narrower-Than-Expected Loss Meets Negative Stock ReactionProfit Inflection Point - https://www.dars.gov.et/
Stock splits calendar for: - Yahoo Finance Australia
Matinas BioPharma Holdings, Inc. Revenue Breakdown – GETTEX:6LJ - TradingView
Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – FWB:6LJ - TradingView
Book value per share of Matinas BioPharma Holdings, Inc. – MUN:6LJ - TradingView
Form DEF 14A Matinas BioPharma Holdings Inc For: 29 September By Investing.com - Investing.com Canada
Form DEF 14A Matinas BioPharma Holdings Inc For: 29 September By Investing.com - Investing.com UK
Stock splits calendar for: - Yahoo Finance Singapore
Stock splits calendar for: - Yahoo Finance Singapore
Matinas BioPharma (MTNB) Climbs 8.4% as Sub-$1 Biotech Pushes Toward $0.18 ResistanceInitial Balance - siam.in
Matinas BioPharma (MTNB) Climbs 8.4% as Sub-$1 Biotech Pushes Toward $0.18 ResistancePre-Earnings Momentum - dars.gov.et
Matinas BioPharma announces one-for-fifteen reverse stock split approval By Investing.com - Investing.com India
Matinas BioPharma announces one-for-fifteen reverse stock split approval - Investing.com
Matinas BioPharma announces one-for-fifteen reverse stock split approval By Investing.com - Investing.com Australia
Form 8K Matinas BioPharma Holdings Inc For: 16 September By Investing.com - Investing.com Nigeria
Matinas BioPharma announces one-for-fifteen reverse stock split approval By Investing.com - Investing.com Canada
Form 8K Matinas BioPharma Holdings Inc For: 16 September By Investing.com - Investing.com Canada
Matinas BioPharma to implement 1-for-15 reverse stock split effective Sept. 28, 2026 - TradingView
Form 8K Matinas BioPharma Holdings Inc For: 16 September By Investing.com - Investing.com UK
A first commercial hydrogen deal covers up to 1,000 kilograms a day from GH Power’s facility. - Stock Titan
Price to sales forward of Matinas Biopharma Holdings, Inc. – BOATS:MTNB - TradingView
Matinas BioPharma Share PriceMTNB, RNS News, Articles, Quotes, & Charts (OTCMKTS:MTNB) - Proactive financial news
Matinas Biopharma (MTNB) Holds Steady at $0.18 as Key Support HoldsDark Pool Prints - careplusvn.com
Matinas BioPharma Receives New NYSE American Delisting Risk on Equity Shortfall - minichart.com.sg
Matinas BioPharma Faces NYSE American Compliance Challenges - TipRanks
Matinas BioPharma Receives NYSE American Noncompliance Notice for Continued Listing Standards - Quiver Quantitative
Matinas BioPharma Received Notice of Noncompliance - tradingview.com
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - Yahoo Finance
Matinas (MTNB) Results Review: EPS Lands Above Forecast in the Latest Reading; Closing Move: Shares Finish 1.16% Down at the ClosePerformance Review - vinanet.vn
Hydrogen startup GH Power lines up deal with Matinas BioPharma (NYSE: MTNB) - stocktitan.net
Matinas (MTNB) Session: Finishes 1.16% Down at $0.20 on the Day; Levels: the Near-Term Reference Band Stretches From $0.19 to $0.21 in the Current UpdateWave Equality - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingShare Repurchase Impact - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingWeak Earnings Momentum - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingProduct Revenue Analysis - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingEarnings Outlook Update - careplusvn.com
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingBuyback Announcement Report - careplusvn.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Top Premarket Decliners - marketscreener.com
Matinas (MTNB) Results Review: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Market Response: The Stock Loses 8.33%Earnings Trend Analysis - vinanet.vn
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesRevenue Warning Signal - vinanet.vn
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesRevenue Surprise History - dars.gov.et
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesReturn On Equity - dars.gov.et
Matinas BioPharma (MTNB) holder Adam Stern details 9.99% stake and new warrants - Stock Titan
Matinas Biopharma (MTNB) Slips 2.6% to $0.26 as Micro-Cap Biotech Tests SupportBreakout Stock Alerts - careplusvn.com
Matinas Biopharma (MTNB) Slips 2.6% to $0.26 as Micro-Cap Biotech Tests SupportZero Gamma Level - vinanet.vn
US Micro Cap StocksInvest from India - INDmoney
Matinas Biopharma Holdings Inc (MTNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.22%
자본화:
|
볼륨(24시간):